New R&D hub aims for digitally-integrated manufacturing processes
A new Australian Research Council (ARC) Hub to help forge an internationally competitive Australian biopharmaceutical sector using digitisation and artificial intelligence (AI) in pharmaceutical manufacturing has been launched at the University of Melbourne. ARC Acting CEO Dr Richard Johnson inaugrated the ARC Digital Bioprocess Development Hub – a five-year, $18 million research programme, which has…